X @Bloomberg

Novo will slash 11% of staff globally as it fights to recover ground lost to obesity-drug rivals. Can the pharma giant answer its critics and keep the competition at bay?🎧 Bloomberg reporters took your questions in a Live Q&A. Listen back: https://t.co/spNxngJear ...